Not registered yet? Please contact our project manager Dr. Sara Stöber . This area is only for members of the research consortium.



This section keeps you updated on any major developments throughout the course of the PANCAID project.

  • Save the date: UEG week

    United European Gastroenterology (UEG) will host UEG Week, a must-visit congress for gastroenterology. From 14 – 17 October 2023, UEG Week will take place both in-person in Copenhagen, Denmark and virtually. We’re especially excited, as PANCAID co-coordinator Prof. Matthias Löhr (KI), will give the introductory lecture during the session “Autoimmune pancreatitis: The story continues” (14 October, 13:30 – 15:00). Additionally, he will chair the session “Update on chronic pancreatitis: How to diagnose and how to treat?” (15 October, 15:30 – 16:30).

    More info:

  • World Pancreatic Cancer Day

    Today, 14th November, marks a significant day globally — World Pancreatic Cancer Day. It’s a day initiated by the World Pancreatic Cancer Coalition and dedicated to raising awareness about pancreatic cancer, an illness often diagnosed in its advanced stages and known for its low survival rates.

    Key Facts:

    1. Silent Threat: Pancreatic cancer is often called a “silent” disease because its symptoms can be subtle and easily attributed to other causes. This underscores the importance of paying attention to one’s body and seeking medical attention for persistent or unusual symptoms.
    2. Low Survival Rates: Pancreatic cancer has one of the lowest survival rates among major cancers. This emphasizes the urgency of early detection and underscores the need for continued research to develop more effective treatment strategies.
    3. Risk Factors: Understanding the risk factors associated with pancreatic cancer, such as family history, smoking, and certain genetic conditions, is crucial. Lifestyle changes and regular health check-ups can contribute to early intervention.

    We aim to take on the the biggest challenge in the clinical management of pancreatic cancer: the current inability to diagnose it in time. Read more on our research approach here.

  • PANCAID Newsletter – Summer 2023

    🚀Our first newsletter just hit inboxes! 📨
    Missed it? We got you! Simply read it online.

    Subscribe to our mailing list to receive up-to-date information on what’s happening at PANCAID!

  • World RNA Day

    Today is World RNA Day. A day to celebrate the versatility of ribonucleic acid (RNA).

    RNA, especially microRNA, also plays an important role in our research: Part of PANCAID work package 2 is profiling multi-omics data, where we analyse genomic, epigenomic, transcriptomic, microRNA and metabolomic data from patients with pancreatic cancer and individuals at risk.

    Read more about RNA Day:

  • PANCAID 2nd Steering Committee Meeting

    Our second Steering Committee Meeting took place in a virtual format on 22 June 2023. During the meeting, work package leaders presented and discussed the overall status of their respective work package. With fruitful discussions, the consortium solidified the path for the coming months.

  • First press release published

    We are delighted to share the first press release, introducing PANCAID, an EU-funded project to develop a blood test for early detection of pancreatic cancer to the wider public.

    Read the full press release here.

    View other press releases here.

  • PANCAID Kick-Off Meeting

    PANCAID comprises 17 partners from eight countries (Germany, Sweden, Spain, Austria, Belgium, France, Israel, and the United Kingdom), as part of the Horizon Europe programme and EU Mission: Cancer.

    The project, as well as funding by the EC started on 1 January 2023. The involved scientists kicked off the project from 13 to 15 February in Hamburg, Germany.